The outcome of composite bone graft substitute used to treat cavitary bone defects

Orthopedics

Volumn 31, Issue 8, 2008, Pages 754-

  Siegel, Herrick J ^a,d   Baird III, Robert C ^a   Hall, Justin ^b   Lopez Ben, Robert ^c   Lander, Philip H ^c  

^a Section of Orthopedic Oncology

^b School of Medicine

^c University of Alabama   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; SILICATE; VITOSS;

ADULT; AGED; ARTICLE; AUTOGRAFT; BONE DEFECT; BONE GRAFT; BONE MARROW; BONE MARROW BIOPSY; BONE RADIOGRAPHY; CHILD; COMPOSITE GRAFT; FEMALE; FUNCTIONAL STATUS; GROUPS BY AGE; HUMAN; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OSTEOLYSIS; PATIENT SAFETY; RADIOLOGIST; SCHOOL CHILD; STEM CELL; TREATMENT OUTCOME; ADOLESCENT; BONE MARROW TRANSPLANTATION; BONE PROSTHESIS; BONE TRANSPLANTATION; CLINICAL TRIAL; FRACTURE; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; CHILD; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; SILICATES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 64949201193     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20080801-31     Document Type: Article

References (14)

1. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989; 3(3):192-195.
2. Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg. 1995; 3(1):1-8.
3. Lindholm TS, Urist MR. A quantitative analysis of new bone formation by induction in compositive grafts of bone marrow and bone matrix. Clin Orthop Relat Res. 1980; (150):288-300. (Pubitemid 10039067)
4. Bucholz RW, Carlton A, Holmes RE. Hydroxyapatite and tricalcium phosphate bone graft substitutes. OrthopClin North Am. 1987; 18(2):323-334. (Pubitemid 17061158)
5. Anker CJ, Holdridge SP, Baird B, Cohen H, Damron TA. Ultraporous beta-tricalcium phosphate is well incorporated in small cavitary defects. Clin Orthop Relat Res. 2005; (434):251-257. (Pubitemid 40617525)
6. Hollinger JO, Brekke J, Gruskin E, Lee D. Role of bone substitutes. Clin Orthop Relat Res. 1996; (324):55-65. (Pubitemid 26071751)
7. Tiedeman JJ, Garvin KL, Kile TA, Connolly JF. The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects. Orthopedics. 1995; 18(12):1153-1158.
8. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res. 1995; (313):8-18.
9. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997; 79(11):1699-1709. (Pubitemid 27508530)
10. Ohgushi H, Goldberg VM, Caplan AI. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop Scand. 1989; 60(3):334-339.
11. Green E, Hinton C, Triffitt JT. The effect of decalcified bone matrix on the osteogenic potential of bone marrow. Clin Orthop Relat Res. 1986; (205):292-298. (Pubitemid 16011281)
12. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res. 1991; (266):259-270.
13. Tiedeman JJ, Connolly JF, Strates BS, Lippiello L. Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. Clin Orthop Relat Res. 1991; (268):294-302.
14. Stevenson S. Enhancement of fracture healing with autogenous and allogeneic bone grafts. Clin Orthop Relat Res. 1998; (355 Suppl):239-246.